Invesco Ltd. Kinnate Biopharma Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.5 - $25.48 $146,949 - $226,924	-8,906 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $158,615 - $221,492	8,906 New	8,906 $205,000
Q1 2021 May 17, 2021	SELL	$26.99 - $40.0 $4.52 Million - $6.7 Million	-167,383 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $6.08 Million - $7.57 Million	167,383 New	167,383 $6.66 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.